Already a member? Sign in
Category: Prescription Drugs
Most Popular Types: Xyrem
Generic Name: Sodium Oxybate
Sodium oxybate is the salt form of the drug gamma-Hydroxybutyric acid (4-hydroxybutanoic acid, C4H8O3), commonly abbreviated GHB. Historically, GHB has been used in a medical setting as a general anesthetic, to treat conditions such as insomnia, clinical depression, narcolepsy, and alcoholism.
Read more...
| Purpose | # of patients |
# of patients with evaluations
Efficacy
|
Major | Moderate | Slight | None | Can’t tell |
|---|---|---|---|---|---|---|---|
| Sleeplessness | 9 | 3 |
|
|
|
||
| Fibromyalgia | 7 | 1 |
|
||||
| Pain | 6 | 3 |
|
|
|||
| Difficulty sleeping through night | 4 | 2 |
|
|
|||
| Narcolepsy | 4 | 1 |
|
||||
| Excessive daytime sleepiness (somnolence) | 4 | 1 |
|
See all 29 patients currently taking Sodium Oxybate
Mouse over the table for more information
Commonly reported side effects, conditions, and hospitalizations associated with Sodium Oxybate
| Nausea | 2 | |
|---|---|---|
| Sweating excessive | 2 | |
| Sleep Walking | 2 | |
| Headaches | 2 | |
| anesthesia | 1 | |
| Increased insomnia | 1 | |
| See all 11 reported side effects ▼ | ||
Frequently reported dosages based on patients currently taking Sodium Oxybate. See all 18 dosages ►
| Reason | # Patients | Percentage of patients | |
|---|---|---|---|
| Side effects too severe | 4 | ||
| Did not seem to work | 1 | ||
| Expense | 1 | ||
| Course of treatment ended | 1 |
Adherence
Taking treatment as prescribed
Adherence of Sodium Oxybate
Always |
9 | 90% |
|
|---|---|---|---|
Usually |
1 | 10% |
|
Sometimes |
0 | 0% |
|
Never |
0 | 0% |
|
Burden
Difficulty being on treatment
Burden of Sodium Oxybate
Very |
0 | 0% |
|
|---|---|---|---|
Somewhat |
3 | 30% |
|
A little |
3 | 30% |
|
Not at all |
4 | 40% |
|
Cost
Paid out of pocket
Cost of Sodium Oxybate
$200+ |
3 | 38% |
|
|---|---|---|---|
$100-199 |
0 | 0% |
|
$50-99 |
0 | 0% |
|
$25-49 |
2 | 25% |
|
< $25 |
3 | 38% |
|
See more information, including instructions, precautions, side effects, and interactions.
Report created on February 12, 2012.